micropulse laser photocoagulation
Proceduremicropulse laser photocoagulation in treatment of diabetic macular edema, 5% duty cycle
NCT Number: NCT07266597
To assess the safety and efficacy of 532 nm subthreshold micropulse laser 5 % duty cycle compared with 15 % duty cycle in treatment of diabetic macular edema .
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
prospective interventional randomized comparative study that will be conducted on Patients with diabetic retinopathy who Are More than 18 years old with diabetic macular edema with a central retinal thickness < 400 um and best corrected visual acuity between 6/18 and 6/60 .
The participants will be divided randomly into two groups All Patients will receive single session of 532 nm subthreshold micropulse laser ,the following parameters will be used in all cases as follows,spot size : 200-µm ,exposure duration:200-ms ,power : 500-mW
While duty cycle will differ between 2 groups as follows :- Group A : will be treated using 5 % duty cycle . Group B : will be treated using 15 % duty cycle . follow up visits as follows 1 week ,4 weeks 12 weeks after laser therapy .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with diabetic retinopathy who:
Exclusion criteria
micropulse laser photocoagulation in treatment of diabetic macular edema, 5% duty cycle
Time frame: 3 months
assessment of change of central macular thickness before and after laser treatment
Contact information is provided by the study sponsor or research team.
mortada ahmed abu zeid, professor
CONTACT
younis shabaan abu alhassan, resident
CONTACT
Sohag University
Other
Micropulse Laser Photocoagulation Treatment of Diabetic Macular Edema ; 5 % Versus 15 % Duty Cycle
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07604545
Diabetic Macular Edema
View Trial DetailsNCT07383701
Diabetic Macular Edema
Boston, Massachusetts, United States
View Trial DetailsNCT07567898
Diabetic Macular Edema, Eye Diseases
View Trial DetailsNCT07481500
Behavior, Cardiovascular Diseases
View Trial Details